Case - Fungal urosepsis after ureteroscopy in a patient on new generation of anti-hyperglycemic medication.
作者信息
Abdi Hamidreza, Locke Eric, Fitzpatrick Ryan, Oake Jeffery Stuart
机构信息
Department of Surgery, Division of Urology, University of Ottawa, Ottawa, ON, Canada.
出版信息
Can Urol Assoc J. 2019 Jul;13(7):E226-E228. doi: 10.5489/cuaj.5635.
Abstract
摘要
相似文献
1
Case - Fungal urosepsis after ureteroscopy in a patient on new generation of anti-hyperglycemic medication.病例——一名正在使用新一代降糖药物的患者输尿管镜检查后发生真菌性脓毒症。
Can Urol Assoc J. 2019 Jul;13(7):E226-E228. doi: 10.5489/cuaj.5635.
2
Analysis of Factors' Association with Risk of Postoperative Urosepsis in Patients Undergoing Ureteroscopy for Treatment of Stone Disease.输尿管镜治疗结石病患者术后尿脓毒症风险相关因素分析
J Endourol. 2016 Sep;30(9):963-9. doi: 10.1089/end.2016.0300. Epub 2016 Jul 13.
3
Beware! Fungal urosepsis may follow endoscopic intervention for prolonged indwelling ureteral stent.
J Endourol. 2006 Jul;20(7):522-4. doi: 10.1089/end.2006.20.522.
4
The value of procalcitonin for predicting urosepsis after mini-percutaneous nephrolithotomy or flexible ureteroscopy based on different organisms.基于不同病原体，降钙素原对微创经皮肾镜取石术或软性输尿管镜术后尿脓毒症的预测价值。
World J Urol. 2022 Feb;40(2):529-535. doi: 10.1007/s00345-021-03845-9. Epub 2021 Oct 6.
5
Outcomes of Elective Ureteroscopy for Ureteric Stones in Patients with Prior Urosepsis and Emergency Drainage: Prospective Study over 5 yr from a Tertiary Endourology Centre.既往脓毒症并急诊引流患者行选择性输尿管镜取石术治疗输尿管结石的结局：来自一家三级内镜中心的 5 年前瞻性研究。
Eur Urol Focus. 2020 Jan 15;6(1):151-156. doi: 10.1016/j.euf.2018.09.001. Epub 2018 Sep 13.
6
Identification of Factors Associated with Postoperative Urosepsis after Ureteroscopy with Holmium: Yttrium-Aluminum-Garnet Laser Lithotripsy.钬激光：钇铝石榴石激光碎石术输尿管镜检查术后与术后尿脓毒症相关因素的识别
Urol Int. 2019;103(3):311-317. doi: 10.1159/000502159. Epub 2019 Aug 28.
7
Predictors of Urinary Infections and Urosepsis After Ureteroscopy for Stone Disease: a Systematic Review from EAU Section of Urolithiasis (EULIS).输尿管镜取石术后尿路感染和尿脓毒症的预测因素：欧洲泌尿外科学会尿石症分会（EULIS）的系统评价
Curr Urol Rep. 2020 Mar 24;21(4):16. doi: 10.1007/s11934-020-0969-2.
8
Risk Factors for Urosepsis After Ureteroscopy for Stone Disease: A Systematic Review with Meta-Analysis.结石病输尿管镜检查后尿脓毒症的危险因素：系统评价与荟萃分析。
J Endourol. 2021 Jul;35(7):991-1000. doi: 10.1089/end.2020.1133. Epub 2021 Mar 15.
9
A Machine Learning Predictive Model for Post-Ureteroscopy Urosepsis Needing Intensive Care Unit Admission: A Case-Control YAU Endourology Study from Nine European Centres.一种用于预测输尿管镜检查后需要入住重症监护病房的尿脓毒症的机器学习预测模型：一项来自九个欧洲中心的YAU泌尿外科病例对照研究。
J Clin Med. 2021 Aug 29;10(17):3888. doi: 10.3390/jcm10173888.
10
Fungal urosepsis after ureteroscopy in cirrhotic patients: a word of caution.肝硬化患者输尿管镜检查后真菌性泌尿道感染：需谨慎对待
Urology. 2008 Aug;72(2):291-3. doi: 10.1016/j.urology.2008.01.005. Epub 2008 May 12.
本文引用的文献
1
Risks Associated with SGLT2 Inhibitors: An Overview.与钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂相关的风险：概述
Curr Drug Saf. 2018;13(2):84-91. doi: 10.2174/1574886313666180226103408.
2
Clinical risk factors predicting genital fungal infections with sodium-glucose cotransporter 2 inhibitor treatment: The ABCD nationwide dapagliflozin audit.预测钠-葡萄糖协同转运蛋白2抑制剂治疗引起生殖器真菌感染的临床危险因素：ABCD全国性达格列净审计
Prim Care Diabetes. 2018 Feb;12(1):45-50. doi: 10.1016/j.pcd.2017.06.004. Epub 2017 Jun 29.
3
Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials.使用钠-葡萄糖协同转运蛋白2抑制剂治疗的2型糖尿病患者的泌尿道和生殖器感染：一项随机对照试验的荟萃分析
Diabetes Obes Metab. 2017 Mar;19(3):348-355. doi: 10.1111/dom.12825. Epub 2016 Dec 19.
4
Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials.恩格列净用于2型糖尿病：3期临床试验概述
Curr Diabetes Rev. 2017;13(4):405-423. doi: 10.2174/1573399812666160613113556.
5
Sodium-glucose cotransporter-2 inhibitors and genital and urinary tract infections in type 2 diabetes.2型糖尿病中钠-葡萄糖协同转运蛋白2抑制剂与泌尿生殖道感染
Postgrad Med. 2016 May;128(4):409-17. doi: 10.1080/00325481.2016.1167570. Epub 2016 Apr 4.
6
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.恩格列净：在 2 型糖尿病中的心血管结局和死亡率。
N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17.
7
Aspergillus infection in urinary tract post-ureteric stenting.输尿管支架置入术后泌尿道曲霉菌感染
Indian J Med Microbiol. 2015 Apr-Jun;33(2):316-8. doi: 10.4103/0255-0857.154895.
8
CUA Guidelines on antibiotic prophylaxis for urologic procedures.加拿大泌尿外科协会关于泌尿外科手术抗生素预防的指南。
Can Urol Assoc J. 2015 Jan-Feb;9(1-2):13-22. doi: 10.5489/cuaj.2382.
9
Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences.探索钠-葡萄糖协同转运蛋白2（SGLT2）作为糖尿病治疗靶点：基础生理学及影响
Diab Vasc Dis Res. 2015 Mar;12(2):78-89. doi: 10.1177/1479164114561992. Epub 2015 Jan 23.
10
Adverse effects and safety of SGLT-2 inhibitors.钠-葡萄糖协同转运蛋白 2 抑制剂的不良反应和安全性。
Diabetes Metab. 2014 Dec;40(6 Suppl 1):S28-34. doi: 10.1016/S1262-3636(14)72693-X.
Zotero 插件